FDA Investigator Lori Peters
Lori Peters has conducted inspections on 8 sites in 3 countries as of 02 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
02 May 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America,
Mexico,
Italy
FDA Investigators that have inspected at least one site in common with Lori Peters:
Althea A Williams,
Amber D Brodas,
Anthony W Thomas,
Antonina Aydanian,
Burnell M Henry,
CDR Donald Ertel,
Charles Jewell,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Cynthia Jim, CSO,
Daniel T Lee,
Deborah M Trout,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Diane L Raccasi,
Dr. Guang Gao, PhD,
Edward A Brunt,
Erin L Mcfiren,
Esra Toussaint,
Freyja V Lynn,
Gene D Arcy,
Helen B Ricalde,
Jacob M Dyer,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
James C Maclaughlin,
Jennifer L Bridgewater,
Jennifer L Schmidt,
Jin Gao,
Jude C Dikes,
Justine M Corson,
Karen L Kosar,
Kathleen R Jones, PhD,
Kellie L Thommes, RN,
Kent A Conforti,
Kevin A Gonzalez,
Kristina L Conroy,
Lata C Mathew, PhD,
Lewis K Antwi,
Lori S Lawless,
Maria Joselopez Barragan, PhD,
Marjorie A Shapiro, PhD,
Marlene L Davis,
Marsha W Major,
Martha T Olone,
Mary Davis Lopez,
Maryna C Eichelberger, PhD,
Mate Tolnay,
Matthew A Spataro,
Michael C Kennedy, PhD,
Mihaly S Ligmond,
Milan S Blake,
Miriam M Ngundi,
Nancy T Waites,
Nicole C Victoria, PhD,
Nicole K Trudel,
Omotunde O Osunsanmi,
Patricia D Gardner,
Paul Mouris,
Paula A Trost,
Perry T Nichols,
Prabhu P Raju,
Priscilla M Pastrana,
Qiao Y Bobo,
Ralph A Erickson,
Richard W Thornton,
Robert Jennings,
Robert W Fisher,
Ronald T Nowalk,
Rose Ashley,
Sarah B Tanksley,
Scott E Norris,
Scott T Ballard,
Simone E Pitts,
Susan F Laska, MS,
Susan M Jackson,
Tammy L Chavis,
Thai D Truong,
Tina S Roecklein,
Travis S Bradley,
Wayne E Seifert,
Yvins Dezan
Lori Peters's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2009 | EIR | Instituto Bioclon S.A. de C.V. - EIR, 2009-06-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more